{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:13:10Z","timestamp":1759335190560},"reference-count":70,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1097\/01.dad.0000164604.56650.26","type":"journal-article","created":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T09:02:45Z","timestamp":1138784565000},"page":"48-55","source":"Crossref","is-referenced-by-count":23,"title":["Adverse Antibiotic-Induced Eruptions Associated With Epstein Barr Virus Infection and Showing Kikuchi-Fujimoto Disease-Like Histology"],"prefix":"10.1097","volume":"28","author":[{"given":"J Andrew","family":"Carlson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Perlmutter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellis","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Rohwedder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-10-20210202","first-page":"765","article-title":"Rates of cutaneous reactions to drugs.","volume":"137","author":"Bigby","year":"2001","journal-title":"Arch Dermatol"},{"key":"R2-10-20210202","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1440-0960.1995.tb00953.x","article-title":"Mechanisms of drug eruptions: Part I.","volume":"36","author":"Breathnach","year":"1995","journal-title":"Australas J Dermatol"},{"key":"R3-10-20210202","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2165\/00128071-200304060-00005","article-title":"Progress in the understanding of the pathology and pathogenesis of cutaneous drug eruptions: implications for management.","volume":"4","author":"Crowson","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"R4-10-20210202","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1001\/archderm.140.2.226","article-title":"Is a drug alone sufficient to cause the drug hypersensitivity syndrome?","volume":"140","author":"Wong","year":"2004","journal-title":"Arch Dermatol"},{"key":"R5-10-20210202","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/archderm.1994.01690050095017","article-title":"Drug rashes. What are the targets of cell-mediated cytotoxicity?","volume":"130","author":"Chosidow","year":"1994","journal-title":"Arch Dermatol"},{"key":"R6-10-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199716010-00001","article-title":"Role of viral infections in the induction of adverse drug reactions.","volume":"16","author":"Levy","year":"1997","journal-title":"Drug Saf"},{"key":"R7-10-20210202","first-page":"357","article-title":"The drug hypersensitivity syndrome: what is the pathogenesis?","volume":"137","author":"Sullivan","year":"2001","journal-title":"Arch Dermatol"},{"key":"R8-10-20210202","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1365-2133.2001.04151.x","article-title":"Kikuchis disease and the skin: case report and review of the literature.","volume":"144","author":"Yasukawa","year":"2001","journal-title":"Br J Dermatol"},{"key":"R9-10-20210202","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00000478-199909000-00006","article-title":"The histopathology of cutaneous lesions of Kikuchis disease (necrotizing lymphadenitis): a report of five cases.","volume":"23","author":"Spies","year":"1999","journal-title":"Am J Surg Pathol"},{"key":"R10-10-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00000372-199902000-00044","article-title":"Compare your diagnosis. Xanthogranuloma, seborrheic keratosis associated with mycosis fungoides, Kikuchis disease.","volume":"21","author":"Ackerman","year":"1999","journal-title":"Am J Dermatopathol"},{"key":"R12-10-20210202","first-page":"493","article-title":"The ampicillin rash as a diagnostic and management problem: case reports and literature review.","volume":"7","author":"Geyman","year":"1978","journal-title":"J Fam Pract"},{"key":"R13-10-20210202","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/clinids\/13.4.697","article-title":"Adverse virus-drug interactions.","volume":"13","author":"Haverkos","year":"1991","journal-title":"Rev Infect Dis"},{"key":"R14-10-20210202","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0895-4356(98)00041-9","article-title":"Skin reactions to antibacterial agents in general practice.","volume":"51","author":"van der Linden","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"R15-10-20210202","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1046\/j.1365-4362.2001.00081.x","article-title":"Which intercurrent infections are associated with maculopapular cutaneous drug reactions? A case-control study.","volume":"40","author":"Cohen","year":"2001","journal-title":"Int J Dermatol"},{"key":"R16-10-20210202","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0140-6736(67)91893-4","article-title":"Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis.","volume":"2","author":"Pullen","year":"1967","journal-title":"Lancet"},{"key":"R17-10-20210202","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/inf.1972.4.issue-3.09","article-title":"Ampicillin sensitivity in infectious mononucleosis-temporary or permanent?","volume":"4","author":"Nazareth","year":"1972","journal-title":"Scand J Infect Dis"},{"key":"R18-10-20210202","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1365-2222.1997.tb02987.x","article-title":"Allergic reactions to ampicillin. Studies on the specificity and selectivity in subjects with immediate reactions.","volume":"27","author":"Romano","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"R19-10-20210202","first-page":"330","article-title":"Making a rash diagnosis: amoxicillin therapy in infectious mononucleosis.","volume":"83","author":"Pauszek","year":"1990","journal-title":"Indiana Med"},{"key":"R20-10-20210202","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1046\/j.1365-4362.2003.01699_1.x","article-title":"Eruption associated with amoxicillin in a patient with infectious mononucleosis.","volume":"42","author":"Leung","year":"2003","journal-title":"Int J Dermatol"},{"key":"R21-10-20210202","first-page":"521","article-title":"Methicillin rash in infectious mononucleosis.","volume":"133","author":"Fields","year":"1980","journal-title":"West J Med"},{"key":"R22-10-20210202","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(76)90252-X","article-title":"Letter: Infectious-mononucleosis rash after talampicillin.","volume":"1","author":"Morris","year":"1976","journal-title":"Lancet"},{"key":"R23-10-20210202","first-page":"222","article-title":"Letter: Pivampicillin (ampicillin) and infectious mononucleosis.","volume":"78","author":"Glennie","year":"1973","journal-title":"N Z Med J"},{"key":"R24-10-20210202","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1542\/peds.40.5.910","article-title":"Skin rash with infectious mononucleosis and ampicillin.","volume":"40","author":"Patel","year":"1967","journal-title":"Pediatrics"},{"key":"R25-10-20210202","first-page":"251","article-title":"Cephalexin rash in infectious mononucleosis.","volume":"59","author":"McCloskey","year":"1997","journal-title":"Cutis"},{"key":"R26-10-20210202","first-page":"91","article-title":"An infectious mononucleosis-like syndrome induced by minocycline: a third pattern of adverse drug reaction.","volume":"64","author":"Lupton","year":"1999","journal-title":"Cutis"},{"key":"R27-10-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1346-8138.2000.tb02192.x","article-title":"Quinolone drug rash in a patient with infectious mononucleosis.","volume":"27","author":"Paily","year":"2000","journal-title":"J Dermatol"},{"key":"R28-10-20210202","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1742-1241.1989.tb08808.x","article-title":"Erythromycin rash in glandular fever.","volume":"43","author":"Pendleton","year":"1989","journal-title":"Br J Clin Pract"},{"key":"R29-10-20210202","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/0036554021000026949","article-title":"Azithromycin-induced rash in infectious mononucleosis.","volume":"34","author":"Dakdouki","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"R30-10-20210202","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1365-2222.2001.01164.x","article-title":"T cell involvement in cutaneous drug eruptions.","volume":"31","author":"Hari","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"R31-10-20210202","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00128071-200203040-00001","article-title":"Cellular and molecular pathophysiology of cutaneous drug reactions.","volume":"3","author":"Pichler","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"R32-10-20210202","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1001\/archderm.1997.03890400081011","article-title":"Role of delayed cellular hypersensitivity and adhesion molecules in amoxicillin-induced morbilliform rashes.","volume":"133","author":"Barbaud","year":"1997","journal-title":"Arch Dermatol"},{"key":"R33-10-20210202","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1365-2133.2003.05321.x","article-title":"Slow acetylator genotypes as a possible risk factor for infectious mononucleosis-like syndrome induced by salazosulfapyridine.","volume":"148","author":"Ohtani","year":"2003","journal-title":"Br J Dermatol"},{"key":"R34-10-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0733-8635(01)00014-6","article-title":"Cutaneous manifestations of Epstein-Barr virus infection.","volume":"20","author":"Ikediobi","year":"2002","journal-title":"Dermatol Clin"},{"key":"R35-10-20210202","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1398-9995.1995.tb05066.x","article-title":"Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes.","volume":"50","author":"Romano","year":"1995","journal-title":"Allergy"},{"key":"R36-10-20210202","first-page":"478","article-title":"Drug hypersensitivity syndrome in a West-Indian population.","volume":"13","author":"Muller","year":"2003","journal-title":"Eur J Dermatol"},{"key":"R37-10-20210202","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1046\/j.1365-2133.2003.05330.x","article-title":"Drug-induced hypersensitivity syndrome associated with Epstein-Barr virus infection.","volume":"148","author":"Descamps","year":"2003","journal-title":"Br J Dermatol"},{"key":"R38-10-20210202","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1525-1470.2001.01931.x","article-title":"Minocycline hypersensitivity syndrome with hypotension mimicking septic shock.","volume":"18","author":"Colvin","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"R39-10-20210202","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1001\/archderm.1997.03890460044005","article-title":"Comparative safety of tetracycline, minocycline, and doxycycline.","volume":"133","author":"Shapiro","year":"1997","journal-title":"Arch Dermatol"},{"key":"R40-10-20210202","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00428-003-0918-8","article-title":"The plasmacytoid monocyte\/interferon producing cells.","volume":"443","author":"Facchetti","year":"2003","journal-title":"Virchows Arch"},{"key":"R41-10-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00000372-200002000-00002","article-title":"Comparative immunophenotypic study of lichen sclerosus: epidermotropic CD57+ lymphocytes are numerous-implications for pathogenesis.","volume":"22","author":"Carlson","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"R42-10-20210202","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0031-3955(05)70573-3","article-title":"What every pediatrician should know about infectious mononucleosis in adolescents.","volume":"44","author":"Hickey","year":"1997","journal-title":"Pediatr Clin North Am"},{"key":"R43-10-20210202","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1473-3099(03)00543-7","article-title":"Epstein-Barr virus-recent advances.","volume":"3","author":"Macsween","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"R45-10-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1346-8138.1993.tb01299.x","article-title":"Atypical exanthema in a patient with infectious mononucleosis.","volume":"20","author":"Kato","year":"1993","journal-title":"J Dermatol"},{"key":"R46-10-20210202","doi-asserted-by":"crossref","first-page":"511","DOI":"10.7326\/0003-4819-112-7-511","article-title":"Detection of Epstein-Barr virus in epidermal skin lesions of an immunocompromised patient.","volume":"112","author":"Fermand","year":"1990","journal-title":"Ann Intern Med"},{"key":"R47-10-20210202","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1001\/archderm.1993.01680310094017","article-title":"Interface dermatitis. How specific are its histopathologic features?","volume":"129","author":"LeBoit","year":"1993","journal-title":"Arch Dermatol"},{"key":"R48-10-20210202","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1136\/bmj.1.5647.846-b","article-title":"Ampicillin and urticaria.","volume":"1","author":"Knudsen","year":"1969","journal-title":"BMJ"},{"key":"R49-10-20210202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1398-9995.1997.tb02550.x","article-title":"Immediate hypersensitivity to penicillins. Studies on Italian subjects.","volume":"52","author":"Romano","year":"1997","journal-title":"Allergy"},{"key":"R50-10-20210202","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/1523-1747.ep12260501","article-title":"Morbilliform eruptions caused by penicillin. A study by electron microscopy and immunologic tests.","volume":"55","author":"Fellner","year":"1970","journal-title":"J Invest Dermatol"},{"key":"R51-10-20210202","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00126334-200008010-00007","article-title":"Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.","volume":"24","author":"Para","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R52-10-20210202","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1046\/j.1365-2133.2002.05021.x","article-title":"Amoxicillin-induced exanthema in young adults with infectious mononucleosis: demonstration of drug-specific lymphocyte reactivity.","volume":"147","author":"Renn","year":"2002","journal-title":"Br J Dermatol"},{"key":"R53-10-20210202","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/archderm.134.9.1113","article-title":"Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6.","volume":"134","author":"Tohyama","year":"1998","journal-title":"Arch Dermatol"},{"key":"R54-10-20210202","first-page":"301","article-title":"Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms.","volume":"137","author":"Descamps","year":"2001","journal-title":"Arch Dermatol"},{"key":"R55-10-20210202","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/00015550310007481","article-title":"Human herpes virus 6 encephalitis in allopurinol-induced hypersensitivity syndrome.","volume":"83","author":"Masaki","year":"2003","journal-title":"Acta Derm Venereol"},{"key":"R56-10-20210202","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1046\/j.1523-1747.2003.12333.x","article-title":"Active human herpesvirus 6 infection in a patient with drug rash with eosinophilia and systemic symptoms.","volume":"121","author":"Descamps","year":"2003","journal-title":"J Invest Dermatol"},{"key":"R58-10-20210202","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1309\/N4E2-78V9-QTFH-X4FF","article-title":"Kikuchi-Fujimoto disease. Is Epstein-Barr virus the culprit?","volume":"113","author":"Hudnall","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"R59-10-20210202","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/01.SMJ.0000054420.01333.B0","article-title":"Is human herpesvirus 6 linked to Kikuchi-Fujimoto disease? The importance of consistent molecular and serologic analysis.","volume":"96","author":"Dominguez","year":"2003","journal-title":"South Med J"},{"key":"R60-10-20210202","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1177\/014556130208100511","article-title":"Kikuchis disease: a case report and review of the literature.","volume":"81","author":"Baumgartner","year":"2002","journal-title":"Ear Nose Throat J"},{"key":"R61-10-20210202","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/00000478-199009000-00009","article-title":"Cutaneous manifestation of Kikuchis histiocytic necrotizing lymphadenitis.","volume":"14","author":"Kuo","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"R62-10-20210202","first-page":"292","article-title":"An ultrastructural study of subacute necrotizing lymphadenitis.","volume":"107","author":"Imamura","year":"1982","journal-title":"Am J Pathol"},{"key":"R63-10-20210202","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1309\/1A6Y-YCKP-5AVF-QTYR","article-title":"Virus infection in patients with histiocytic necrotizing lymphadenitis in Taiwan. Detection of Epstein-Barr virus, type I human T-cell lymphotropic virus, and parvovirus B19.","volume":"113","author":"Chiu","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"R64-10-20210202","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1542\/peds.104.2.e24","article-title":"Kikuchis disease with multisystemic involvement and adverse reaction to drugs.","volume":"104","author":"Sierra","year":"1999","journal-title":"Pediatrics"},{"key":"R65-10-20210202","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1084\/jem.20021091","article-title":"Interferon-producing cells fail to induce proliferation of naive T cells but can promote expansion and T helper 1 differentiation of antigen-experienced unpolarized T cells.","volume":"197","author":"Krug","year":"2003","journal-title":"J Exp Med"},{"key":"R66-10-20210202","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s102420200027","article-title":"[Plasmacytoid monocytes and plasmacytoid dendritic cells. Immune system cells linking innate and acquired immunity].","volume":"94","author":"Facchetti","year":"2002","journal-title":"Pathologica"},{"key":"R67-10-20210202","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1097\/00000478-199507000-00008","article-title":"Kikuchis disease (histiocytic necrotizing lymphadenitis). A clinicopathologic study of 79 cases with an analysis of histologic subtypes, immunohistology, and DNA ploidy.","volume":"19","author":"Kuo","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R68-10-20210202","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1080\/1042819031000082984","article-title":"Differential chemokine, chemokine receptor and cytokine expression in Epstein-Barr virus-associated lymphoproliferative diseases.","volume":"44","author":"Ohshima","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"R69-10-20210202","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1056\/NEJM199307153290304","article-title":"Brief report: severe infectious mononucleosis-like syndrome and primary human herpesvirus 6 infection in an adult.","volume":"329","author":"Akashi","year":"1993","journal-title":"N Engl J Med"},{"key":"R70-10-20210202","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1440-1827.1995.tb03420.x","article-title":"A case of human herpesvirus-6 lymphadenitis with infectious mononucleosis-like syndrome.","volume":"45","author":"Sumiyoshi","year":"1995","journal-title":"Pathol Int"},{"key":"R71-10-20210202","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/inf.1970.2.issue-1.05","article-title":"Hypersensitivity reactions to ampicillin in cytomegalovirus mononucleosis.","volume":"2","author":"Klemola","year":"1970","journal-title":"Scand J Infect Dis"},{"key":"R72-10-20210202","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0190-9622(97)80413-6","article-title":"EBV-associated Kikuchis histiocytic necrotizing lymphadenitis with cutaneous manifestations.","volume":"36","author":"Yen","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"R73-10-20210202","first-page":"2155","article-title":"Human herpesviruses HHV-4 (EBV) and HHV-6 in Hodgkins and Kikuchis diseases and their relation to proliferation and apoptosis.","volume":"21","author":"Krueger","year":"2001","journal-title":"Anticancer Res"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00000372-200602000-00010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T10:35:02Z","timestamp":1683369302000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-200602000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.dad.0000164604.56650.26","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}